United States Heparine Market Report 2017

August 2017 | 107 pages | ID: U584C764327EN
QYResearch

Abstracts

In this report, the United States Heparine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Heparine in these regions, from 2012 to 2022 (forecast).

United States Heparine market competition by top manufacturers/players, with Heparine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• GlaxoSmithKline (GSK)
• Leo Pharma
• Pfizer
• Sanofi
• Alchemi
• Vaxter
• BMS
• Boehringer Ingelheim
• Celgene
• Cosmo Pharmaceuticals
• Dr.Reddy's Laboratories

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• LMWH
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Heparine for each application, including

• IV injection/infusion
• SC injection

Contents

United States Heparine Market Report 2017

1 HEPARINE OVERVIEW

1.1 Product Overview and Scope of Heparine
1.2 Classification of Heparine by Product Category
  1.2.1 United States Heparine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Heparine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 LMWH
  1.2.4 Others
1.3 United States Heparine Market by Application/End Users
  1.3.1 United States Heparine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 IV injection/infusion
  1.3.3 SC injection
1.4 United States Heparine Market by Region
  1.4.1 United States Heparine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Heparine Status and Prospect (2012-2022)
  1.4.3 Southwest Heparine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Heparine Status and Prospect (2012-2022)
  1.4.5 New England Heparine Status and Prospect (2012-2022)
  1.4.6 The South Heparine Status and Prospect (2012-2022)
  1.4.7 The Midwest Heparine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Heparine (2012-2022)
  1.5.1 United States Heparine Sales and Growth Rate (2012-2022)
  1.5.2 United States Heparine Revenue and Growth Rate (2012-2022)

2 UNITED STATES HEPARINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Heparine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Heparine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Heparine Average Price by Players/Suppliers (2012-2017)
2.4 United States Heparine Market Competitive Situation and Trends
  2.4.1 United States Heparine Market Concentration Rate
  2.4.2 United States Heparine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Heparine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HEPARINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Heparine Sales and Market Share by Region (2012-2017)
3.2 United States Heparine Revenue and Market Share by Region (2012-2017)
3.3 United States Heparine Price by Region (2012-2017)

4 UNITED STATES HEPARINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Heparine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Heparine Revenue and Market Share by Type (2012-2017)
4.3 United States Heparine Price by Type (2012-2017)
4.4 United States Heparine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HEPARINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Heparine Sales and Market Share by Application (2012-2017)
5.2 United States Heparine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HEPARINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GlaxoSmithKline (GSK)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Heparine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GlaxoSmithKline (GSK) Heparine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Leo Pharma
  6.2.2 Heparine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Leo Pharma Heparine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.2 Heparine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Heparine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi
  6.4.2 Heparine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi Heparine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Alchemi
  6.5.2 Heparine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Alchemi Heparine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Vaxter
  6.6.2 Heparine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Vaxter Heparine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 BMS
  6.7.2 Heparine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 BMS Heparine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Boehringer Ingelheim
  6.8.2 Heparine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Boehringer Ingelheim Heparine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Celgene
  6.9.2 Heparine Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Celgene Heparine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Cosmo Pharmaceuticals
  6.10.2 Heparine Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Cosmo Pharmaceuticals Heparine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Dr.Reddy's Laboratories

7 HEPARINE MANUFACTURING COST ANALYSIS

7.1 Heparine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Heparine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Heparine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Heparine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HEPARINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Heparine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Heparine Sales Volume Forecast by Type (2017-2022)
11.3 United States Heparine Sales Volume Forecast by Application (2017-2022)
11.4 United States Heparine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Heparine
Figure United States Heparine Market Size (K Units) by Type (2012-2022)
Figure United States Heparine Sales Volume Market Share by Type (Product Category) in 2016
Figure LMWH Product Picture
Figure Others Product Picture
Figure United States Heparine Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Heparine by Application in 2016
Figure IV injection/infusion Examples
Figure SC injection Examples
Figure United States Heparine Market Size (Million USD) by Region (2012-2022)
Figure The West Heparine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Heparine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Heparine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Heparine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Heparine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Heparine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Heparine Sales (K Units) and Growth Rate (2012-2022)
Figure United States Heparine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Heparine Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Heparine Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Heparine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Heparine Sales Share by Players/Suppliers
Figure 2017 United States Heparine Sales Share by Players/Suppliers
Figure United States Heparine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Heparine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Heparine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Heparine Revenue Share by Players/Suppliers
Figure 2017 United States Heparine Revenue Share by Players/Suppliers
Table United States Market Heparine Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Heparine Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Heparine Market Share of Top 3 Players/Suppliers
Figure United States Heparine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Heparine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Heparine Product Category
Table United States Heparine Sales (K Units) by Region (2012-2017)
Table United States Heparine Sales Share by Region (2012-2017)
Figure United States Heparine Sales Share by Region (2012-2017)
Figure United States Heparine Sales Market Share by Region in 2016
Table United States Heparine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Heparine Revenue Share by Region (2012-2017)
Figure United States Heparine Revenue Market Share by Region (2012-2017)
Figure United States Heparine Revenue Market Share by Region in 2016
Table United States Heparine Price (USD/Unit) by Region (2012-2017)
Table United States Heparine Sales (K Units) by Type (2012-2017)
Table United States Heparine Sales Share by Type (2012-2017)
Figure United States Heparine Sales Share by Type (2012-2017)
Figure United States Heparine Sales Market Share by Type in 2016
Table United States Heparine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Heparine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Heparine by Type (2012-2017)
Figure Revenue Market Share of Heparine by Type in 2016
Table United States Heparine Price (USD/Unit) by Types (2012-2017)
Figure United States Heparine Sales Growth Rate by Type (2012-2017)
Table United States Heparine Sales (K Units) by Application (2012-2017)
Table United States Heparine Sales Market Share by Application (2012-2017)
Figure United States Heparine Sales Market Share by Application (2012-2017)
Figure United States Heparine Sales Market Share by Application in 2016
Table United States Heparine Sales Growth Rate by Application (2012-2017)
Figure United States Heparine Sales Growth Rate by Application (2012-2017)
Table GlaxoSmithKline (GSK) Basic Information List
Table GlaxoSmithKline (GSK) Heparine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline (GSK) Heparine Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline (GSK) Heparine Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline (GSK) Heparine Revenue Market Share in United States (2012-2017)
Table Leo Pharma Basic Information List
Table Leo Pharma Heparine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Leo Pharma Heparine Sales Growth Rate (2012-2017)
Figure Leo Pharma Heparine Sales Market Share in United States (2012-2017)
Figure Leo Pharma Heparine Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Heparine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Heparine Sales Growth Rate (2012-2017)
Figure Pfizer Heparine Sales Market Share in United States (2012-2017)
Figure Pfizer Heparine Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Heparine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Heparine Sales Growth Rate (2012-2017)
Figure Sanofi Heparine Sales Market Share in United States (2012-2017)
Figure Sanofi Heparine Revenue Market Share in United States (2012-2017)
Table Alchemi Basic Information List
Table Alchemi Heparine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alchemi Heparine Sales Growth Rate (2012-2017)
Figure Alchemi Heparine Sales Market Share in United States (2012-2017)
Figure Alchemi Heparine Revenue Market Share in United States (2012-2017)
Table Vaxter Basic Information List
Table Vaxter Heparine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Vaxter Heparine Sales Growth Rate (2012-2017)
Figure Vaxter Heparine Sales Market Share in United States (2012-2017)
Figure Vaxter Heparine Revenue Market Share in United States (2012-2017)
Table BMS Basic Information List
Table BMS Heparine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BMS Heparine Sales Growth Rate (2012-2017)
Figure BMS Heparine Sales Market Share in United States (2012-2017)
Figure BMS Heparine Revenue Market Share in United States (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Heparine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Heparine Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim Heparine Sales Market Share in United States (2012-2017)
Figure Boehringer Ingelheim Heparine Revenue Market Share in United States (2012-2017)
Table Celgene Basic Information List
Table Celgene Heparine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celgene Heparine Sales Growth Rate (2012-2017)
Figure Celgene Heparine Sales Market Share in United States (2012-2017)
Figure Celgene Heparine Revenue Market Share in United States (2012-2017)
Table Cosmo Pharmaceuticals Basic Information List
Table Cosmo Pharmaceuticals Heparine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cosmo Pharmaceuticals Heparine Sales Growth Rate (2012-2017)
Figure Cosmo Pharmaceuticals Heparine Sales Market Share in United States (2012-2017)
Figure Cosmo Pharmaceuticals Heparine Revenue Market Share in United States (2012-2017)
Table Dr.Reddy's Laboratories Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Heparine
Figure Manufacturing Process Analysis of Heparine
Figure Heparine Industrial Chain Analysis
Table Raw Materials Sources of Heparine Major Players/Suppliers in 2016
Table Major Buyers of Heparine
Table Distributors/Traders List
Figure United States Heparine Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Heparine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Heparine Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Heparine Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Heparine Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Heparine Sales Volume (K Units) Forecast by Type in 2022
Table United States Heparine Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Heparine Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Heparine Sales Volume (K Units) Forecast by Application in 2022
Table United States Heparine Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Heparine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Heparine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Heparine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources